---
title: CDMO Daily News — June 15, 2026
slug: daily-news-2026-06-15-cdmo
site: cdmo
post_kind: news
byline: BioBM
last_updated: 2026-06-15T23:59:41.939Z
---

### CCRM's OmniaBio Partners with [Avectas](/companies/avectas) to Advance Automated Cell Therapy Manufacturing
- OmniaBio, Canada's largest cell and gene therapy CDMO, will evaluate [Avectas](/companies/avectas)' automated manufacturing platform to enhance scalability and efficiency.
- CCRM is expanding its global hub-and-spoke network across Canada, Australia, Nordic countries, and a planned Ireland facility to support regional advanced therapy manufacturing.
- The partnership targets automation, cost reduction, and standardization challenges that currently limit patient access to cell and gene therapies.

**Operational Impact**

OmniaBio's evaluation of [Avectas](/companies/avectas)' platform could enhance its Intelligent Factory capabilities and support CCRM's planned Ireland hub, potentially increasing regional manufacturing capacity and reducing time-to-patient for cell therapies across EMEA and APAC.

*Source: [PR Newswire pharma category RSS](https://www.prnewswire.com/news-releases/ccrm-omniabio-and-avectas-partner-to-improve-cell-therapy-manufacturing-302799943.html)*

## References

1. [PR Newswire pharma category RSS — CCRM's OmniaBio Partners with [Avectas](/companies/avectas) to Advance Automated Cell Therapy Manufacturing](https://www.prnewswire.com/news-releases/ccrm-omniabio-and-avectas-partner-to-improve-cell-therapy-manufacturing-302799943.html)

Source: https://cdmo.directory/posts/daily-news-2026-06-15-cdmo